Ohcanbohtosat - Jiří Mayer
- Čájehuvvo 1 - 20 / 95
- Sirdás čuovvovaš siidui
-
1
Total psoriasis regression in a patient with chronic myeloid leukemia treated using nilotinib Dahkki Tomáš Horňák, Daniela Žáčková, Jiřı́ Mayer
Almmustuhtton 2025Artigo -
2
MicroRNA BIOGENESIS, FUNCTIONALITY AND CANCER RELEVANCE Dahkki Branislav Kusenda, Marek Mráz, Jiří Mayer, Šárka Pospı́šilová
Almmustuhtton 2006Revisão -
3
Reduced Nephrotoxicity of Conventional Amphotericin B Therapy after Minimal Nephroprotective Measures: Animal Experiments and Clinical Study Dahkki Jiřı́ Mayer, Michael Doubek, J. Doubek, Drahomír Horký, Peter Scheer, Marek Štěpánek
Almmustuhtton 2002Artigo -
4
-
5
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia Dahkki Wojciech Jurczak, Krzysztof Chojnowski, Jiřı́ Mayer, Katarzyna Krawczyk, Brian Jamieson, Wei Tian, Lee F. Allen
Almmustuhtton 2018Artigo -
6
Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic Leukemia Dahkki Peter Hillmen, Aleksander B. Skotnicki, Tadeusz Robak, Branimir Jakšić, Anna Dmoszyńska, Jingyang Wu, Cynthia A. Sirard, Jiřı́ Mayer
Almmustuhtton 2007Artigo -
7
Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program Dahkki James B. Bussel, Donald M. Arnold, Michael Boxer, Nichola Cooper, Jiřı́ Mayer, Hany Zayed, Sandra Tong, Anne‐Marie Duliège
Almmustuhtton 2019Artigo -
8
Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia Dahkki Zdeněk Ráčil, Filip Rázga, J. Drápalová, Lucie Burešová, Daniela Žáčková, Martina Palacková, Lukáš Semerád, Ludmila Malášková, Martin Haluzı́k, Jiřı́ Mayer
Almmustuhtton 2013Carta -
9
Difficulties in using 1,3-β-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies – high frequency of fa... Dahkki Zdeněk Ráčil, Iva Kocmanová, Martina Lengerová, Barbora Weinbergerová, Lucie Burešová, Martina Tošková, Jana Winterová, Shira Timilsina, I. E. Rodríguez, Jiřı́ Mayer
Almmustuhtton 2010Artigo -
10
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Dahkki Uwe Platzbecker, Argiris Symeonidis, Esther Natalie Olíva, Jeroen S. Goede, Michel Delforge, Jiří Mayer, Bohrane Slama, Sejal Badre, Eduard Gasal, Bhakti Mehta, Janet Franklin
Almmustuhtton 2017Artigo -
11
Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases—the role of factors affecting assay perf... Dahkki Zdeněk Ráčil, Iva Kocmanová, Martina Tošková, Lucie Burešová, Barbora Weinbergerová, Martina Lengerová, Monika Rolencová, Jana Winterová, Kristýna Hrnčířová, Pavlína Volfová, Jana Skřičková, Jiřı́ Mayer
Almmustuhtton 2011Artigo -
12
Rapid Detection and Identification of Mucormycetes in Bronchoalveolar Lavage Samples from Immunocompromised Patients with Pulmonary Infiltrates by Use of High-Resolution Melt Analy... Dahkki Martina Lengerová, Zdeněk Ráčil, Kristýna Hrnčířová, Iva Kocmanová, Pavlína Volfová, Dita Říčná, Petr Bejdák, Mojmír Moulis, Zdeněk Pavlovský, Barbora Weinbergerová, Martina Tošková, Jiřı́ Mayer
Almmustuhtton 2014Artigo -
13
Rapid Detection and Identification of Mucormycetes from Culture and Tissue Samples by Use of High-Resolution Melt Analysis Dahkki Kristýna Hrnčířová, Martina Lengerová, Iva Kocmanová, Zdeněk Ráčil, Pavlína Volfová, Dita Paloušová, Mojmír Moulis, Barbora Weinbergerová, Jana Winterová, Martina Tošková, Šárka Pospı́šilová, Jiřı́ Mayer
Almmustuhtton 2010Artigo -
14
Five-Year Results and Overall Survival Update from the Phase 3 Randomized Study Augment: Lenalidomide Plus Rituximab (R2) Vs Rituximab Plus Placebo in Patients with Relapsed/Refrac... Dahkki John P. Leonard, Marek Trněný, Fritz Offner, Jiří Mayer, Huilai Zhang, Grzegorz S. Nowakowski, Phillip Scheinberg, Argyrios Gkasiamis, Joanna Mikita-Geoffroy, Everton Rowe, John G. Gribben
Almmustuhtton 2022Artigo -
15
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b Dahkki Jean‐Jacques Kiladjian, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Hasselbalch, Róbert Královics, Heinz Gisslinger, Jean‐Jacques Kiladjian, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Heinz Gisslinger
Almmustuhtton 2022Carta -
16
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial Dahkki Jorge E. Cortés, Giuseppe Saglio, Hagop M. Kantarjian, Michele Baccarani, Jiřı́ Mayer, Concepción Boqué, Neil P. Shah, Charles Chuah, Luís Casanova, Brigid Bradley-Garelik, George Manos, Andreas Hochhaus
Almmustuhtton 2016Artigo -
17
Robust acute myeloid leukemia engraftment in humanized scaffolds using injectable biomaterials and intravenous xenotransplantation Dahkki Daniel Buša, Zdeňka Herudková, Jan Hyl, Jakub Vlažný, Filip Sokol, Kvetoslava Matulova, Adam Folta, Jakub Hynšt, Lucy Vojtová, Leoš Křen, Martin Repko, Zdeněk Ráčil, Jiří Mayer, Martin Čulen
Almmustuhtton 2025Artigo -
18
Missense Mutations Located in Structural p53 DNA-Binding Motifs Are Associated With Extremely Poor Survival in Chronic Lymphocytic Leukemia Dahkki Martin Trbušek, Jana Šmardová, Jitka Malčíková, Ludmila Šebejová, Petr Dobeš, Miluše Svitáková, Vladimíra Vranová, Marek Mráz, Hana Skuhrová Francová, Michael Doubek, Yvona Brychtová, Petr Kuglík, Šárka Pospı́šilová, Jiřı́ Mayer
Almmustuhtton 2011Artigo -
19
Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP <i>versus</i> R-CHOP in the phase 3 LYM-3002 study Dahkki Gregor Verhoef, Tadeusz Robak, Huiqiang Huang, Halyna Pylypenko, Noppadol Siritanaratkul, Juliana Pereira, Johannes Drach, Jiřı́ Mayer, Rumiko Okamoto, Lixia Pei, Brendan Rooney, Andrew Cakana, Helgi van de Velde, Franco Cavalli
Almmustuhtton 2017Artigo -
20
Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis Dahkki Gabriela Mladonická Pavlasová, Marek Borský, Václav Šeda, Kateřina Amruz Černá, Jitka Osičková, Michael Doubek, Jiřı́ Mayer, Raffaele Calogero, Martin Trbušek, Šárka Pospı́šilová, Matthew S. Davids, Thomas J. Kipps, Jennifer R. Brown, Marek Mráz
Almmustuhtton 2016Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Oncology
Gastroenterology
Myeloid leukemia
Surgery
Biology
Leukemia
Immunology
Genetics
Lymphoma
Chemotherapy
Gene
Adverse effect
Chronic lymphocytic leukemia
Rituximab
Clinical endpoint
Randomized controlled trial
Transplantation
Cancer research
Clinical trial
Cancer
Imatinib
Confidence interval
Hazard ratio
Cyclophosphamide
Ibrutinib
Pathology
Physics
Environmental health